Welcome to our dedicated page for Lifestance Health Group news (Ticker: LFST), a resource for investors and traders seeking the latest updates and insights on Lifestance Health Group stock.
LifeStance Health Group, Inc. (LFST) provides investors and industry observers with timely access to corporate developments through this centralized news hub. Track official press releases, regulatory filings, and strategic announcements from one of the nation's leading outpatient mental healthcare providers.
Key resources include: Earnings reports detailing financial performance, partnership announcements with healthcare networks, expansions of clinical services, and leadership updates. This curated collection serves as a primary source for understanding LFST's operational milestones and market positioning.
All content reflects the company's focus on evidence-based behavioral healthcare and its commitment to expanding access through innovative care models. Regular updates ensure stakeholders stay informed about developments in teletherapy advancements, clinical research collaborations, and regulatory compliance matters.
Bookmark this page for direct access to LFST's verified corporate communications, eliminating the need to search multiple sources. Check back frequently for updates on operational metrics, facility expansions, and other material events shaping the company's trajectory in mental healthcare.
LifeStance Health Group, Inc. (NASDAQ: LFST), a leading outpatient mental health care provider, will present at the Goldman Sachs 43rd Annual Global Healthcare Conference on June 15, 2022, at 11:20 a.m. PT. CEO Michael Lester, COO Danish Qureshi, and CFO J. Michael Bruff will present at the event moderated by Jamie Perse. Attendees can access the live webcast on LifeStance's Investor Relations website, where a replay will also be available. Danish Qureshi's appointment as COO takes effect on July 1, 2022.
LifeStance Health (NASDAQ: LFST) announces the retirement of COO Gwen Booth, who will become Executive Director of the LifeStance Health Foundation, which aims to improve mental health access. Danish Qureshi, previously Chief Growth Officer, has been appointed as the new COO effective July 1, 2022. Booth has been with the company since its founding in 2017. Qureshi has a strong track record in growing the company and enhancing mental health services. The Foundation, established in 2021, has already awarded over $400,000 to support mental health initiatives.
LifeStance Health (NASDAQ: LFST), a leading provider in outpatient mental health care, will present at the UBS Global Healthcare Conference on May 25, 2022. Presenters include CEO Michael Lester, CFO J. Michael Bruff, and Chief Growth Officer Danish Qureshi. The presentation is scheduled for 7:45 a.m. Eastern time and will be moderated by Kevin Caliendo. A live webcast will be available on the LifeStance Health Investor Relations website, with a replay following the event. LifeStance employs approximately 5,000 professionals across 32 states.
LifeStance Health Group, Inc. (NASDAQ: LFST) reported Q1 2022 revenue of $203.1 million, a 42% increase from the prior year. Total clinicians grew 51% to 4,989, with a net addition of 199 clinicians. However, net loss surged to $62.3 million, primarily due to stock-based compensation costs of $59.9 million. Adjusted EBITDA remained stable at $12.5 million. The company reaffirmed full-year 2022 revenue guidance of $865 million to $885 million.
LifeStance Health Group, Inc. (NASDAQ: LFST) is set to release its first quarter earnings on May 9, 2022, after market close. Following the earnings announcement, the company will conduct a conference call at 4:30 p.m. ET to discuss its financial performance. Interested participants can join via a toll-free number or listen to a live webcast through LifeStance's Investor Relations website. Founded in 2017, LifeStance is a major provider of outpatient mental health care, employing roughly 4,800 professionals across 32 states.
LifeStance Health Group (LFST) reported a 61% revenue growth in Q4 2021, reaching $190.1 million, and a full-year revenue of $667.5 million, up 77% from 2020. However, the company posted a net loss of $108 million for Q4 and $307.2 million for the full year, primarily due to stock-based compensation. LifeStance anticipates a revenue growth rate in the low 30s for 2022, with expected revenue between $865 and $885 million. The company expanded its clinician base by 55% to 4,790 clinicians, demonstrating its ongoing growth strategy.
LifeStance Health Group (NASDAQ: LFST), a leading provider of outpatient mental health care, will announce its fourth quarter earnings on March 10, 2022, after market close. A conference call to discuss the results is scheduled for the same day at 4:30 PM ET. Investors can join by calling 1-888-660-0230 or via webcast at the LifeStance Investor Relations site. Established in 2017, LifeStance operates around 500 centers and employs about 4,375 mental health professionals across 31 states, striving to enhance access to affordable mental health care.
LifeStance Health, a leading provider of outpatient mental health care, will present at the 40th Annual J.P. Morgan Healthcare Conference on January 12, 2022, at 1:30 p.m. ET. CEO Michael Lester and Chief Digital Officer Pablo Pantaleoni will lead the presentation, moderated by Lisa Gill. Attendees can access the live webcast on the Investor Relations section of their website, with a replay available post-event. Established in 2017, LifeStance operates 500 centers across 31 states and employs over 4,375 mental health professionals, committed to enhancing access to affordable mental healthcare.
LifeStance Health (NASDAQ: LFST) announced its certification as a Great Place to Work, based on positive feedback from its approximately 6,000 employees. This recognition reflects LifeStance's commitment to employee well-being and engagement. CEO Michael Lester and Chief People Officer Felicia Gorcyca emphasized the importance of mental health and the company's dedication to enhancing workplace culture through initiatives like professional development programs, improved wellness benefits, and community involvement. LifeStance operates approximately 500 centers across 31 states, focusing on accessible mental healthcare.